Figure 4.
Effects of semaglutide vs. placebo on the time to first loop diuretic start among non-users at baseline (A) and time to first loop diuretic stop in users at baseline (B), pooled across the STEP-HFpEF and STEP-HFpEF-DM trials
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.